Trump Vaccine Exemption Executive Order: What GCs and Global Employers Must Know About Emerging Immunisation Compliance Risk

What the Executive Order Actually Does

President Trump signed an executive order that pursues two linked objectives: it establishes a set of so-called "Gold Standard Childhood Vaccine Recommendations" that would narrow the diseases for which universal childhood immunisation is required, and it directs the Attorney General to bring litigation against states that refuse to provide both religious and medical exemptions from school immunisation mandates.

The order does not, on its own, alter federal law. Executive orders bind the executive branch and can direct enforcement priorities, but they cannot override statute. Immunisation requirements in the United States are primarily creatures of state law, and that federal-state divide is precisely why the order resorts to threatened litigation rather than direct mandate. For general counsel tracking the development, the immediate legal force is limited but the downstream regulatory and contractual exposure is real and deserves structured attention.

Who Is Bound and on What Timeline

The order binds federal agencies immediately upon signature. The Attorney General is directed to identify states whose immunisation laws fail to accommodate religious and medical exemptions and to pursue legal action against them. No specific litigation timeline is written into the order, so enforcement pace will depend on Justice Department prioritisation and the caseload of its Civil Rights and Federal Programs divisions.

State governments are the primary targets. States that maintain strict immunisation requirements without broad exemption pathways face the prospect of federal litigation, which carries reputational, budgetary and legislative consequences even if the legal outcome is uncertain. Parents, schools, healthcare providers and, critically for commercial lawyers, employers operating in healthcare, education and certain regulated industries sit in the indirect blast radius.

For multinational companies with US operations, the relevant question is whether existing workplace health and safety policies, employment contracts or vendor agreements contain immunisation clauses that now carry fresh legal risk depending on where the work is performed.

The Constitutional Fault Line That Makes This Commercially Significant

US constitutional law has long recognised that states hold the primary police power over public health. The Supreme Court affirmed state authority to mandate vaccination as far back as 1905 in Jacobson v Massachusetts. The federal government's ability to compel states to change their immunisation laws is constrained by anti-commandeering doctrine, which prevents Congress (and by extension the executive branch) from forcing states to administer federal programmes.

The litigation strategy outlined in the order therefore rests on a narrower legal theory: that state immunisation rules which lack religious or medical exemptions may violate federal civil rights protections, including Title VII of the Civil Rights Act for employment contexts and potentially the Religious Freedom Restoration Act in certain settings. That is a litigable but contested argument, and courts have reached varying conclusions in post-pandemic vaccine mandate cases.

For global law firms advising US-based clients, the key point is that legal uncertainty is itself a compliance cost. Employers cannot rely on either state law or federal enforcement posture remaining stable, and contracts drafted without adjustment clauses for regulatory change will be harder to manage.

Contract Clauses That Require Immediate Review

General counsel should audit several categories of contractual provision in light of this order.

First, employment contracts and staff handbooks in healthcare, aged care, education and food production often contain express immunisation requirements as a condition of employment or continued engagement. Where those clauses do not accommodate the exemption categories the federal order promotes, companies face potential claims under Title VII or analogous state statutes.

Second, vendor and staffing agency contracts that pass through immunisation compliance obligations need to be checked for indemnity allocation. If a staffing supplier cannot lawfully enforce immunisation requirements against workers claiming religious exemption, and the host employer's contract treats that as a breach, the indemnity chain becomes disputed.

Third, international employment contracts for staff rotating into US roles should include a governing law and compliance clause that explicitly addresses the possibility of changing immunisation requirements in the host jurisdiction. A clause drafted in, say, the United Kingdom or Singapore that assumes the US host site will maintain a particular vaccine policy may need revision.

Adira's contract review tools can flag immunisation clauses across a document portfolio and surface the jurisdictions where those clauses interact with the evolving federal and state regulatory position, reducing manual review time substantially.

How Other Jurisdictions Are Watching

This development has international dimensions that GCs outside the United States should not dismiss. Several governments, including those in the European Union and the United Kingdom, are monitoring US federal signals on vaccine policy with concern about their effect on cross-border workforce mobility and on the political normalisation of exemption-broadening arguments domestically.

For multinational employers, the practical risk is workforce inconsistency. A global health and safety policy that sets uniform immunisation standards becomes harder to maintain when one major jurisdiction creates legal uncertainty around enforcement. Human resources and legal teams in London, Amsterdam and Singapore advising on global workforce policies should treat the US executive order as a prompt to review whether their global frameworks are genuinely jurisdiction-agnostic or implicitly assume a stable US regulatory position.

Practical Steps for GCs Right Now

The appropriate response is measured, not reactive. Three actions are worth prioritising this quarter.

First, instruct a targeted audit of any employment, vendor or services contract that contains immunisation compliance obligations tied to US state law. Identify which clauses are prescriptive and which include flexibility language that can accommodate regulatory change.

Second, map the workforce. Identify employee populations in US states where immunisation laws are most likely to be challenged or changed under this order, specifically those states with currently strict requirements and no broad exemption pathway.

Third, review your organisation's reasonable accommodation process for religious and medical exemption requests in the US context. A documented, consistent process reduces litigation exposure regardless of how the federal-state legal battle resolves.

The order may not survive constitutional scrutiny in its broadest ambitions. But the period of legal uncertainty it creates is itself a compliance event, and organisations that treat it as one will be better positioned than those that wait for the courts to settle the question.